Atrial fibrillation confers an increased risk for poor outcomes after transcatheter aortic valve replacement (TAVR), but it is not clear how the etiology of AFib influences post-TAVR outcomes.
Source: https://www.medscape.com/viewarticle/938257?src=mbl_msp_android&ref=share